Fundraising FoxACES Diagnostics
Paradise Valley, US · Founded 2024 · Delaware corporation
Find your way into ACES Diagnostics
Sign up to see every warm intro you have to ACES Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ACES Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aces Diagnostics is developing LYMESEEK, an AI-driven blood test for detecting Lyme disease across all stages of the disease, aimed at physicians and clinical laboratories. The single blood-draw test runs on existing lab equipment and is being validated on clinical samples in the U.S. and E.U., with commercial launch anticipated in 2027.
Founders & leadership
ACES Diagnostics was founded in 2024 by Monica Embers, Holly Ahern, and Todd Snowden.
TS
Todd SnowdenFounder & Chief Commercial OfficerTodd Snowden brings 35+ years of experience in medical device, diagnostics, and laboratory services, including roles in product management, sales leadership, and chief executive positions at startup and mid-size firms. His background spans regulatory strategy, commercialization, and international business development across the U.S., Europe, and Latin America.
TC
Tammy CrawfordChief Executive OfficerTammy Crawford is CEO of ACES Diagnostics, where she leads development of an AI-driven blood test for Lyme disease diagnosis. She brings over 25 years of healthcare leadership experience, including roles at Baxter/American Hospital Supply, founding a national events company, and serving as Executive Director of Focus on Lyme, a nonprofit research organization.
LS
Lisa StoneChief Financial Officer
JK
Jim KirkChief Development Officer
PS
Phillip StaffordChief Data OfficerPhillip Stafford is Chief Data Officer at ACES Diagnostics, which develops AI-driven blood tests for disease detection including Lyme disease across all disease stages.
Reported raises · per SEC filings
Form D private placements$4M disclosed across 2 rounds · 2024–2026
▶$400KraisedJun 2026 · 2 investors · OtherRule 506(b)
▶$400KraisedJun 2026 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tammy CrawfordExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $400K
- Minimum investment
- $25K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$3.6MraisedJun 2026 · 27 investors · OtherRule 506(b)
▶$3.6MraisedJun 2026 · 27 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tammy CrawfordExecutive Officer, Director
- Offering amount
- $3.6M
- Amount sold
- $3.6M
- Minimum investment
- $25K
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Quest DiagnosticsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Rupa HealthA platform that enables healthcare providers to order, track, and receive lab test results from multiple laboratory companies through a single dashboard, supporting both in-person and telehealth patients with flexible billing options and EHR integration.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies working in the same space as ACES Diagnostics.
Frequently asked questions
- What does ACES Diagnostics do?
- Aces Diagnostics is developing LYMESEEK, an AI-driven blood test for detecting Lyme disease across all stages of the disease, aimed at physicians and clinical laboratories. The single blood-draw test runs on existing lab equipment and is being validated on clinical samples in the U.S. and E.U., with commercial launch anticipated in 2027.
- Who founded ACES Diagnostics?
- ACES Diagnostics was founded by Monica Embers, Holly Ahern, Todd Snowden in 2024.
- How much funding has ACES Diagnostics raised?
- ACES Diagnostics has disclosed $4M raised across 2 rounds.
- Where is ACES Diagnostics headquartered?
- ACES Diagnostics is headquartered in Paradise Valley, US.